GlassScriptPhysician profile
David W Whiting
NPI 1003836479
$3,575.01
in general payments reported to CMS, 2019-2025
15 companies · $789 in 2025
The $789 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $122 · 2021: $101 · 2022: $1,083 · 2023: $451 · 2024: $552 · 2025: $789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,766 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,766.01 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,265.03 | 2019-2025 | Clareon, Wavelight Refractive Suite, Clareon Panoptix Pro |
| Glaukos Corporation | $229.54 | 2022 | |
| Rxsight INC | $163.28 | 2022-2024 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Johnson & Johnson Surgical Vision, INC. | $144.20 | 2024 | Tecnis Simplicity |
| Ziemer USA | $144.01 | 2023 | Femtoldv |
| Madrigal Pharmaceuticals | $141.60 | 2025 | Rezdiffra |
| Carl Zeiss Meditec, INC. | $115.99 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $98.14 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $75.79 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $54.50 | 2024-2025 | Xdemvy |
| The Cameron-Ehlen Group, INC. | $42.68 | 2020-2022 | |
| Biotissue Holdings INC. | $34.75 | 2025 | |
| Harrow Eye, LLC | $23.96 | 2023 | |
| Shire North American Group INC | $21.18 | 2019 | |
| Bausch & Lomb Americas INC. | $20.36 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Whiting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.